BIO earnings date and history (2026)
Bio-Rad Laboratories Inc. (BIO) next reports earnings on Wed Nov 4. Analysts expect EPS of $2.61 (1 estimate), against $2.26 in the same quarter a year ago. Last time, on Tue Aug 4, it reported $2.62 against a $2.34 consensus (+12.0%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 4, 2026 | $2.34 | $2.62 | — |
| Apr 30, 2026 | $2.77 | $1.89 | — |
| Feb 12, 2026 | $2.57 | $2.51 | — |
| Oct 29, 2025 | $2.30 | $2.26 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does BIO report earnings?
- BIO is scheduled to report on Wed Nov 4, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from BIO?
- The consensus estimate is $2.61 a share across 1 analyst; the same quarter a year ago came in at $2.26.
- Did BIO beat earnings last quarter?
- Yes: on Tue Aug 4 BIO reported $2.62 against a $2.34 consensus, a +12.0% surprise.